Small Cell Carcinoma of Unknown Primary

Seminars in Oncology

Volumn 34, Issue 1, 2007, Pages 39-42

  Lobins, Raymond ^a   Floyd, Justin ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PROCARBAZINE; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GENETICS; CANCER LOCALIZATION; CANCER STAGING; CYTOGENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG SMALL CELL CANCER; METASTASIS; MULTIMODALITY CANCER THERAPY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROGNOSIS; SMALL CELL CARCINOMA; TUMOR BIOPSY; TUMOR DIFFERENTIATION;

CARCINOMA, SMALL CELL; HUMANS; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS;

EID: 33846494895     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2006.10.027     Document Type: Article

References (27)

1. American Cancer Society. Cancer Facts and Figures 2005 (2005), American Cancer Society, Atlanta, GA
2. Galanis E., Frytak S., and Lloyd R.V. Extrapulmonry small cell carcinoma. Cancer 79 (1997) 1729-1739
3. Van der Henricus H., and Heijdra Y.F. Extrapulmonary small cell carcinoma. South Med J 98 (2005) 345-349
4. Hainsworth J.D., Johnson D.H., and Greco A. Poorly differentiated neuroendocrine carcinoma of unknown primary site. Ann Intern Med 109 (1988) 371-394
5. Ghosh L., Dehut W., Kakar S., et al. Management of patients with metastatic cancer of unknown primary. Curr Prob Surg 42 (2005) 12-66
6. Al-Brahim N., Ross C., Carter B., et al. The value of postmortem examination in cases of metastasis of unknown origin-20-year restrospective data from a tertiary care center. Ann Diag Pathol 9 (2005) 77-80
7. Komuro H., Imaizumi S., Hirata A., et al. Congenital mediastinal dumbell neuroblastoma with spontaneous regression of liver metastases. Pediatr Surg Inst 12 (1998) 86-88
8. Abbruzzese J.L., Lenzi R., Raber M.N., et al. The biology of unknown primary tumors. Semin Oncol 20 (1993) 238-243
9. Remick S.C., and Ruckdeschel J.C. Extrapulmonary and pulmonary small cell carcinoma: Tumor biology, therapy, and outcome. Med Pediatr Oncol 20 (1992) 89-99
10. Kim J.H., Lee S., Park J., et al. Extrapulmonary small-cell carcinoma: A single-institution experience. Jpn J Clin Oncol 34 (2004) 250-254
11. Liu J., and Farhood A. Immunostaining for thyroid transcription factor-1 on fine needle aspiration specimens of lung tumors: A comparison of direct smears and cell block preparations. Cancer 102 (2004) 109-114
12. Ordonez N.G. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol 24 (2000) 1217-1223
13. Haider K., Finch D., Ahmed S., et al. Largest series of extrapulmonary small cell carcinoma (ESCC): The Saskatchewan experience. J Clin Oncol 22 suppl 14 (2004) 9681
14. Agoff S.N., Lamos L.W., Folpe A.L., et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendrocrine tumors. Mod Pathol 13 (2000) 238-242
15. Kaufmann O., and Deitel M. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 36 (2000) 415-420
16. Chang Y., Lee Y., Liao W., et al. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Lung Cancer 44 (2004) 149-157
17. Welborn J., Jenks H., Taplett H., et al. High-grade neuroendocrine carcinomas display unique cytogenetic aberratons. Cancer Genet Cytogenet 155 (2004) 33-41
18. Sengoz M., Abacioglu U., Turhal S., et al. Extrapulmonary small cell carcinoma: Multimodality treatment results. Tumori 89 (2003) 274-277
19. Testa J., Liu Z., and Taguchi T. Advances in analysis of chromosome alterations in human lung carcinomas. Cancer Genet Cytogenet 95 (1997) 20-32
20. Michelland S., Gazzeri S., Brambilla E., et al. Comparison of chromosomal imbalances in neuroendocrine and non-small cell lung carcinomas. Cancer Genet Cytogenet 114 (1999) 22-30
21. Kreyberg L., Liebow A., and Uehlinger E. Typing of lung tumors (1967), World Health Organization, Geneva, Switzerland
22. Bennett D., Doll D., and Yarbro W. Bone marrow invovlement in small cell lung cancer. Cancer 63 (1988) 763-766
23. Remick S.C., Hafez G.R., and Carbone P.P. Extrapulmonary small-cell carcinoma. Medicine 66 (1987) 457-471
24. Van de Gaast A., Verwey J., Prins E., et al. Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinoma. Cancer 65 (1990) 422-424
25. Richardson R.L., and Weiland L.H. Undifferentiated small cell carcinomas in extrapulmonary sites. Semin Oncol 9 (1982) 484-496
26. Levenson R.M., Ihde D.C., Minna J.D., et al. Small cell carcinoma presenting as an extrapulmonary neoplasm: Sites of origin and response to chemotherapy. J Natl Cancer Inst 67 (1981) 607-612
27. Orhan B., Yalcin S., Manavoglu O., et al. Sucessful treatment of cranial metastases of extrapulmonary small cell carcinoma with chemotherapy alone. Med Oncol 15 (1998) 66-69